Kunz, Roxanne K.
Rojnuckarin, Atipat
Schmidt, Christian Marc
Miranda, Les P.
Article History
Received: 9 December 2022
Accepted: 25 January 2023
First Online: 1 March 2023
Declarations
:
: CMS is the Founder and a Partner at Schema Design and received funding from Amgen to develop aspects of this work, as outlined in the authors’ contributions statement, and declares no other direct financial relationship with Amgen. All other authors declare they have no competing interests.